(Q38506319)

English

Novel anticancer agent, benzyldihydroxyoctenone, isolated from Streptomyces sp. causes G1 cell cycle arrest and induces apoptosis of HeLa cells

scientific article published on 13 April 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Novel anticancer agent, benzyldihydroxyoctenone, isolated from Streptomyces sp. causes G1 cell cycle arrest and induces apoptosis of HeLa cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Chul-Hoon Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Haeyoung Lim

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sangik Moon

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Choonshik Shin

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Seunghyun Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Bum-Joon Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Yoongho Lim

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

13 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

795-802

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Cdk inhibitors in development and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

p53: good cop/bad cop.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Inhibition of cell-cycle progression in HeLa cells by HY52, a novel cyclin-dependent kinase inhibitor isolated from Bauhinia forficata.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Involvement of poly(ADP-ribose) polymerase in base excision repair

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Inactivation of Bcl-2 by phosphorylation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Apoptotic pathways: the roads to ruin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Pro-caspase-3 is a major physiologic target of caspase-8.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00473.X

21 January 2018

Cell Death in Development

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(00)80564-4

Identifiers

10.1111/J.1349-7006.2007.00473.X

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38506319&oldid=1762714807"